These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Effect of dimecoline on certain clinico-biochemical indicators in patients with hypertensive disease]. Shcherbak VV Vrach Delo; 1974 Mar; (3):31-3. PubMed ID: 4157109 [No Abstract] [Full Text] [Related]
25. [Effectiveness of quateron in hypertension and its effect upon electrolyte metabolism (sodium and potassium)]. Barsegian BA Zh Eksp Klin Med; 1965; 5(5):37-40. PubMed ID: 4379868 [No Abstract] [Full Text] [Related]
26. [The effect of Quateron on coronary circulation in patients with hypertension]. Mnatsakanov TS; Vartapetian PA; Barsegian BA Zh Eksp Klin Med; 1967; 7(3):24-6. PubMed ID: 4390575 [No Abstract] [Full Text] [Related]
27. [Beta-adrenergic blockers and renin-angiotensin-aldosterone system in healthy individuals and patients with arterial hypertension]. Miranda B; Ruilope L; Mancheño E; Arribas F; García-Robles R; Alcázar JM; Nieto J; Sancho J; Rodicio JL Med Clin (Barc); 1984 Nov; 83(14):572-4. PubMed ID: 6513646 [No Abstract] [Full Text] [Related]
28. [Acute obsdrvations of the action of quateron in hypertension]. Mnatsakanov TS; Barsegian BA Zh Eksp Klin Med; 1967; 7(2):31-5. PubMed ID: 4387711 [No Abstract] [Full Text] [Related]
30. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension]. Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989 [No Abstract] [Full Text] [Related]
31. [The behavior of urinary elimination of catecholamines in headache caused by arterial hypertension]. Cavallazzi G; Massara G Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1968; 79(5):636-43. PubMed ID: 4387754 [No Abstract] [Full Text] [Related]
32. [Treatment of hypertensive crises with dicoline and dimecoline]. Vyshinskaia TE Sov Med; 1967 Apr; 30(4):123-7. PubMed ID: 4388818 [No Abstract] [Full Text] [Related]
33. [Treatment of arterial hypertension with alpha-methyldopa]. Herteanu H; Bucur V Med Interna (Bucur); 1969 Sep; 21(9):1119-26. PubMed ID: 5378243 [No Abstract] [Full Text] [Related]
35. [Medico-social aspects of arterial hypertension and clinical considerations on its treatment with the guanoxane-polythiazide combination]. Di Benedetto A; Di Blasi S Minerva Med; 1967 Mar; 58(21):893-6. PubMed ID: 6026542 [No Abstract] [Full Text] [Related]
36. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine]. Montagnani M; Bayelli PF; Antonelli A; Barducci O Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193 [No Abstract] [Full Text] [Related]
37. [The use of catapresan in the treatment of arterial hypertension]. Teodorescu P; Cîmpeanu A Med Interna (Bucur); 1970 Dec; 22(12):1475-86. PubMed ID: 5502468 [No Abstract] [Full Text] [Related]
38. [The clinical picture and treatment of ganglionic syndromes caused by injury]. Urusmambetov ShN Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(5):650-6. PubMed ID: 4399313 [No Abstract] [Full Text] [Related]
39. [Basic trends in the pharmacotherapy of hypertension]. Burchinskiĭ GI Ter Arkh; 1971 Sep; 43(9):117-24. PubMed ID: 4399005 [No Abstract] [Full Text] [Related]
40. [Content of catecholamines in the hypothalamus and different parts of the stomach in experimental ulcer and change in their level under the effect of gangleron]. Mirzoian SA; Virabian TL Zh Eksp Klin Med; 1975; 15(6):3-8. PubMed ID: 4936 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]